Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 330

1.

Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes.

Mantovani A, Sani E, Fassio A, Colecchia A, Viapiana O, Gatti D, Idolazzi L, Rossini M, Salvagno G, Lippi G, Zoppini G, Byrne CD, Bonora E, Targher G.

Diabetes Metab. 2018 Oct 10. pii: S1262-3636(18)30195-2. doi: 10.1016/j.diabet.2018.10.001. [Epub ahead of print]

PMID:
30315891
2.

Dealing With BRCA1/2 Unclassified Variants in a Cancer Genetics Clinic: Does Cosegregation Analysis Help?

Zuntini R, Ferrari S, Bonora E, Buscherini F, Bertonazzi B, Grippa M, Godino L, Miccoli S, Turchetti D.

Front Genet. 2018 Sep 11;9:378. doi: 10.3389/fgene.2018.00378. eCollection 2018.

3.

Genomic profiles of primary and metastatic esophageal adenocarcinoma identified via digital sorting of pure cell populations: results from a case report.

Isidori F, Malvi D, Fittipaldi S, Forcato C, Bozzarelli I, Sala C, Raulli G, D'Errico A, Fiorentino M, Seri M, Krishnadath KK, Bonora E, Mattioli S; EAC-BAGH group.

BMC Cancer. 2018 Sep 12;18(1):889. doi: 10.1186/s12885-018-4789-4.

4.

Association between decreasing estimated glomerular filtration rate and risk of cardiac conduction defects in patients with type 2 diabetes.

Mantovani A, Rigolon R, Turino T, Pichiri I, Falceri A, Rossi A, Temporelli PL, Bonapace S, Lippi G, Zoppini G, Bonora E, Byrne CD, Targher G.

Diabetes Metab. 2018 Dec;44(6):473-481. doi: 10.1016/j.diabet.2018.08.007. Epub 2018 Sep 5.

PMID:
30195089
5.

A renal genetic risk score (GRS) is associated with kidney dysfunction in people with type 2 diabetes.

Zusi C, Trombetta M, Bonetti S, Dauriz M, Boselli ML, Trabetti E, Malerba G, Penno G, Zoppini G, Bonora E, Solini A, Bonadonna RC.

Diabetes Res Clin Pract. 2018 Oct;144:137-143. doi: 10.1016/j.diabres.2018.08.013. Epub 2018 Aug 25.

PMID:
30153470
6.

Impact of a Mediterranean Dietary Pattern and Its Components on Cardiovascular Risk Factors, Glucose Control, and Body Weight in People with Type 2 Diabetes: A Real-Life Study.

Vitale M, Masulli M, Calabrese I, Rivellese AA, Bonora E, Signorini S, Perriello G, Squatrito S, Buzzetti R, Sartore G, Babini AC, Gregori G, Giordano C, Clemente G, Grioni S, Dolce P, Riccardi G, Vaccaro O; TOSCA.IT Study Group.

Nutrients. 2018 Aug 10;10(8). pii: E1067. doi: 10.3390/nu10081067.

7.

Association Between Primary Hypothyroidism and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.

Mantovani A, Nascimbeni F, Lonardo A, Zoppini G, Bonora E, Mantzoros CS, Targher G.

Thyroid. 2018 Oct;28(10):1270-1284. doi: 10.1089/thy.2018.0257. Epub 2018 Aug 30.

PMID:
30084737
8.

Cutaneous squamous carcinoma in a patient with diabetic foot: an unusual evolution of a frequent complication.

Mantovani A, Teobaldi I, Stoico V, Perrone F, Zannoni M, Cima L, Bruti M, Mingolla L, Trombetta M, Bonora E.

Endocrinol Diabetes Metab Case Rep. 2018 Jul 31;2018. pii: 18-0065. doi: 10.1530/EDM-18-0065. eCollection 2018.

9.

Familial Cancer Variant Prioritization Pipeline version 2 (FCVPPv2) applied to a papillary thyroid cancer family.

Kumar A, Bandapalli OR, Paramasivam N, Giangiobbe S, Diquigiovanni C, Bonora E, Eils R, Schlesner M, Hemminki K, Försti A.

Sci Rep. 2018 Aug 2;8(1):11635. doi: 10.1038/s41598-018-29952-z.

10.

Expression of RAD21 immunoreactivity in myenteric neurons of the human and mouse small intestine.

Bianco F, Eisenman ST, Colmenares Aguilar MG, Bonora E, Clavenzani P, Linden DR, De Giorgio R, Farrugia G, Gibbons SJ.

Neurogastroenterol Motil. 2018 Sep;30(9):e13429. doi: 10.1111/nmo.13429. Epub 2018 Aug 1.

PMID:
30069982
11.

From lipoprotein apheresis to proprotein convertase subtilisin/kexin type 9 inhibitors: Impact on low-density lipoprotein cholesterol and C-reactive protein levels in cardiovascular disease patients.

Zenti MG, Altomari A, Lupo MG, Botta M, Bonora E, Corsini A, Ruscica M, Ferri N.

Eur J Prev Cardiol. 2018 Nov;25(17):1843-1851. doi: 10.1177/2047487318792626. Epub 2018 Jul 30.

PMID:
30058841
12.

Non-albuminuric renal impairment is a strong predictor of mortality in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicentre study.

Penno G, Solini A, Orsi E, Bonora E, Fondelli C, Trevisan R, Vedovato M, Cavalot F, Lamacchia O, Scardapane M, Nicolucci A, Pugliese G; Renal Insufficiency And Cardiovascular Events (RIACE) Study Group.

Diabetologia. 2018 Nov;61(11):2277-2289. doi: 10.1007/s00125-018-4691-2. Epub 2018 Jul 21.

PMID:
30032426
13.

Left ventricular chamber dilation and filling pressure may help to categorise patients with type 2 diabetes.

Zoppini G, Bergamini C, Bonapace S, Trombetta M, Mantovani A, Toffalini A, Lanzoni L, Bertolini L, Zenari L, Bonora E, Targher G, Rossi A.

BMJ Open Diabetes Res Care. 2018 Jun 14;6(1):e000529. doi: 10.1136/bmjdrc-2018-000529. eCollection 2018.

14.

Association between nonalcoholic fatty liver disease and colorectal tumours in asymptomatic adults undergoing screening colonoscopy: a systematic review and meta-analysis.

Mantovani A, Dauriz M, Byrne CD, Lonardo A, Zoppini G, Bonora E, Targher G.

Metabolism. 2018 Oct;87:1-12. doi: 10.1016/j.metabol.2018.06.004. Epub 2018 Jun 20.

PMID:
29935236
15.

Mutant MYO1F alters the mitochondrial network and induces tumor proliferation in thyroid cancer.

Diquigiovanni C, Bergamini C, Evangelisti C, Isidori F, Vettori A, Tiso N, Argenton F, Costanzini A, Iommarini L, Anbunathan H, Pagotto U, Repaci A, Babbi G, Casadio R, Lenaz G, Rhoden KJ, Porcelli AM, Fato R, Bowcock A, Seri M, Romeo G, Bonora E.

Int J Cancer. 2018 Apr 19. doi: 10.1002/ijc.31548. [Epub ahead of print]

PMID:
29672841
16.

INPP4B overexpression and c-KIT downregulation in human achalasia.

Bonora E, Bianco F, Stanzani A, Giancola F, Astolfi A, Indio V, Evangelisti C, Martelli AM, Boschetti E, Lugaresi M, Ioannou A, Torresan F, Stanghellini V, Clavenzani P, Seri M, Moonen A, Van Beek K, Wouters M, Boeckxstaens GE, Zaninotto G, Mattioli S, De Giorgio R.

Neurogastroenterol Motil. 2018 Sep;30(9):e13346. doi: 10.1111/nmo.13346. Epub 2018 Apr 11.

PMID:
29644781
17.

Evolocumab and lipoprotein apheresis combination therapy may have synergic effects to reduce low-density lipoprotein cholesterol levels in heterozygous familial hypercholesterolemia: A case report.

Zenti MG, Stefanutti C, Sanga V, Altomari A, Fabris A, Dauriz M, Bonora E.

J Clin Apher. 2018 Aug;33(4):546-550. doi: 10.1002/jca.21632. Epub 2018 Apr 11.

PMID:
29638018
18.

Attending Diabetes Clinics is associated with a lower all-cause mortality. A meta-analysis of observational studies performed in Italy.

Bonora E, Monami M, Bruno G, Zoppini G, Mannucci E.

Nutr Metab Cardiovasc Dis. 2018 May;28(5):431-435. doi: 10.1016/j.numecd.2018.02.009. Epub 2018 Mar 2.

PMID:
29627120
19.

Haemoglobin A1c variability is a strong, independent predictor of all-cause mortality in patients with type 2 diabetes.

Orsi E, Solini A, Bonora E, Fondelli C, Trevisan R, Vedovato M, Cavalot F, Gruden G, Morano S, Nicolucci A, Penno G, Pugliese G; Renal Insufficiency and Cardiovascular Events (RIACE) Study Group.

Diabetes Obes Metab. 2018 Aug;20(8):1885-1893. doi: 10.1111/dom.13306. Epub 2018 Apr 19.

PMID:
29582548
20.

Sex differences in the association of psychological status with measures of physical activity and sedentary behaviour in adults with type 2 diabetes.

Indelicato L, Dauriz M, Bacchi E, Donà S, Santi L, Negri C, Cacciatori V, Bonora E, Nouwen A, Moghetti P.

Acta Diabetol. 2018 Jun;55(6):627-635. doi: 10.1007/s00592-018-1132-0. Epub 2018 Mar 26.

PMID:
29582161
21.

Defining the contribution of chronic kidney disease to all-cause mortality in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study.

Penno G, Solini A, Bonora E, Orsi E, Fondelli C, Zerbini G, Trevisan R, Vedovato M, Cavalot F, Laviola L, Nicolucci A, Pugliese G; Renal Insufficiency and Cardiovascular Events (RIACE) Study Group.

Acta Diabetol. 2018 Jun;55(6):603-612. doi: 10.1007/s00592-018-1133-z. Epub 2018 Mar 24.

PMID:
29574497
22.

Mortality from infectious diseases in diabetes.

Zoppini G, Fedeli U, Schievano E, Dauriz M, Targher G, Bonora E, Corti MC.

Nutr Metab Cardiovasc Dis. 2018 May;28(5):444-450. doi: 10.1016/j.numecd.2017.12.007. Epub 2018 Jan 31.

PMID:
29519560
23.

Association of free-living physical activity measures with metabolic phenotypes in type 2 diabetes at the time of diagnosis. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS).

Dauriz M, Bacchi E, Boselli L, Santi L, Negri C, Trombetta M, Bonadonna RC, Bonora E, Moghetti P.

Nutr Metab Cardiovasc Dis. 2018 Apr;28(4):343-351. doi: 10.1016/j.numecd.2017.12.011. Epub 2018 Jan 9.

PMID:
29477578
24.

Effects of aerobic or resistance exercise training on cardiovascular autonomic function of subjects with type 2 diabetes: A pilot study.

Bellavere F, Cacciatori V, Bacchi E, Gemma ML, Raimondo D, Negri C, Thomaseth K, Muggeo M, Bonora E, Moghetti P.

Nutr Metab Cardiovasc Dis. 2018 Mar;28(3):226-233. doi: 10.1016/j.numecd.2017.12.008. Epub 2018 Jan 2.

PMID:
29402509
25.

Long-Acting GLP-1 Receptor Agonist Exenatide Influence on the Autonomic Cardiac Sympatho-Vagal Balance.

Cacciatori V, Zoppini G, Bellavere F, Rigolon R, Thomaseth K, Pichiri I, Trombetta M, Dauriz M, De Santi F, Targher G, Santi L, Bonora E.

J Endocr Soc. 2017 Nov 6;2(1):53-62. doi: 10.1210/js.2017-00300. eCollection 2018 Jan 1.

26.

Somatic APC mosaicism and oligogenic inheritance in genetically unsolved colorectal adenomatous polyposis patients.

Ciavarella M, Miccoli S, Prossomariti A, Pippucci T, Bonora E, Buscherini F, Palombo F, Zuntini R, Balbi T, Ceccarelli C, Bazzoli F, Ricciardiello L, Turchetti D, Piazzi G.

Eur J Hum Genet. 2018 Mar;26(3):387-395. doi: 10.1038/s41431-017-0086-y. Epub 2018 Jan 24.

27.

Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis.

Mantovani A, Byrne CD, Bonora E, Targher G.

Diabetes Care. 2018 Feb;41(2):372-382. doi: 10.2337/dc17-1902. Review.

PMID:
29358469
28.

Management of diabetes in older adults.

Sesti G, Antonelli Incalzi R, Bonora E, Consoli A, Giaccari A, Maggi S, Paolisso G, Purrello F, Vendemiale G, Ferrara N.

Nutr Metab Cardiovasc Dis. 2018 Mar;28(3):206-218. doi: 10.1016/j.numecd.2017.11.007. Epub 2017 Dec 7.

29.

Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis.

Mantovani A, Zaza G, Byrne CD, Lonardo A, Zoppini G, Bonora E, Targher G.

Metabolism. 2018 Feb;79:64-76. doi: 10.1016/j.metabol.2017.11.003. Epub 2017 Nov 11. Review.

PMID:
29137912
30.

Prognostic Impact of Diabetes on Long-term Survival Outcomes in Patients With Heart Failure: A Meta-analysis.

Dauriz M, Mantovani A, Bonapace S, Verlato G, Zoppini G, Bonora E, Targher G.

Diabetes Care. 2017 Nov;40(11):1597-1605. doi: 10.2337/dc17-0697. Review.

PMID:
29061587
31.
32.

Relation of elevated serum uric acid levels to first-degree heart block and other cardiac conduction defects in hospitalized patients with type 2 diabetes.

Mantovani A, Rigolon R, Pichiri I, Morani G, Bonapace S, Dugo C, Zoppini G, Bonora E, Targher G.

J Diabetes Complications. 2017 Dec;31(12):1691-1697. doi: 10.1016/j.jdiacomp.2017.09.011. Epub 2017 Sep 20.

PMID:
29033310
33.

Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus.

Mantovani A, Rigolon R, Pichiri I, Bonapace S, Morani G, Zoppini G, Bonora E, Targher G.

PLoS One. 2017 Oct 5;12(10):e0185459. doi: 10.1371/journal.pone.0185459. eCollection 2017.

34.

Rationale and design of the DARWIN-T2D (DApagliflozin Real World evIdeNce in Type 2 Diabetes): A multicenter retrospective nationwide Italian study and crowdsourcing opportunity.

Fadini GP, Zatti G, Consoli A, Bonora E, Sesti G, Avogaro A; DARWIN-T2D Network.

Nutr Metab Cardiovasc Dis. 2017 Dec;27(12):1089-1097. doi: 10.1016/j.numecd.2017.08.001. Epub 2017 Aug 8.

PMID:
28967594
35.

Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial.

Vaccaro O, Masulli M, Nicolucci A, Bonora E, Del Prato S, Maggioni AP, Rivellese AA, Squatrito S, Giorda CB, Sesti G, Mocarelli P, Lucisano G, Sacco M, Signorini S, Cappellini F, Perriello G, Babini AC, Lapolla A, Gregori G, Giordano C, Corsi L, Buzzetti R, Clemente G, Di Cianni G, Iannarelli R, Cordera R, La Macchia O, Zamboni C, Scaranna C, Boemi M, Iovine C, Lauro D, Leotta S, Dall'Aglio E, Cannarsa E, Tonutti L, Pugliese G, Bossi AC, Anichini R, Dotta F, Di Benedetto A, Citro G, Antenucci D, Ricci L, Giorgino F, Santini C, Gnasso A, De Cosmo S, Zavaroni D, Vedovato M, Consoli A, Calabrese M, di Bartolo P, Fornengo P, Riccardi G; Thiazolidinediones Or Sulfonylureas Cardiovascular Accidents Intervention Trial (TOSCA.IT) study group; Italian Diabetes Society.

Lancet Diabetes Endocrinol. 2017 Nov;5(11):887-897. doi: 10.1016/S2213-8587(17)30317-0. Epub 2017 Sep 13. Erratum in: Lancet Diabetes Endocrinol. 2017 Nov;5(11):e7.

PMID:
28917544
36.

ANMCO/ISS/AMD/ANCE/ARCA/FADOI/GICR-IACPR/SICI-GISE/SIBioC/SIC/SICOA/SID/SIF/SIMEU/SIMG/SIMI/SISA Joint Consensus Document on cholesterol and cardiovascular risk: diagnostic-therapeutic pathway in Italy.

Gulizia MM, Colivicchi F, Ricciardi G, Giampaoli S, Maggioni AP, Averna M, Graziani MS, Ceriotti F, Mugelli A, Rossi F, Medea G, Parretti D, Abrignani MG, Arca M, Perrone Filardi P, Perticone F, Catapano A, Griffo R, Nardi F, Riccio C, Di Lenarda A, Scherillo M, Musacchio N, Panno AV, Zito GB, Campanini M, Bolognese L, Faggiano PM, Musumeci G, Pusineri E, Ciaccio M, Bonora E, Cantelli Forti G, Ruggieri MP, Cricelli C, Romeo F, Ferrari R, Maseri A.

Eur Heart J Suppl. 2017 May;19(Suppl D):D3-D54. doi: 10.1093/eurheartj/sux029. Epub 2017 May 2.

37.

Hyperuricemia is associated with an increased prevalence of paroxysmal atrial fibrillation in patients with type 2 diabetes referred for clinically indicated 24-h Holter monitoring.

Mantovani A, Rigolon R, Civettini A, Bolzan B, Morani G, Bonapace S, Dugo C, Zoppini G, Bonora E, Targher G.

J Endocrinol Invest. 2018 Feb;41(2):223-231. doi: 10.1007/s40618-017-0729-4. Epub 2017 Jul 15.

PMID:
28711969
38.

Primary cutaneous B-cell lymphoma and chronic leg ulcers in a patient with type 2 diabetes.

Mantovani A, Perrone F, Stoico V, Pichiri I, Salvotelli L, Teobaldi I, Bruti M, Conti M, Cima L, Eccher A, Bonora E.

Endocrinol Diabetes Metab Case Rep. 2017 May 24;2017. pii: 17-0032. doi: 10.1530/EDM-17-0032. eCollection 2017.

39.

Mechanisms linking empagliflozin to cardiovascular and renal protection.

Perrone-Filardi P, Avogaro A, Bonora E, Colivicchi F, Fioretto P, Maggioni AP, Sesti G, Ferrannini E.

Int J Cardiol. 2017 Aug 15;241:450-456. doi: 10.1016/j.ijcard.2017.03.089. Epub 2017 Mar 23. Review.

PMID:
28395981
40.

Association Between Vascular Cell Adhesion Molecule 1 and Atrial Fibrillation.

Willeit K, Pechlaner R, Willeit P, Skroblin P, Paulweber B, Schernthaner C, Toell T, Egger G, Weger S, Oberhollenzer M, Kedenko L, Iglseder B, Bonora E, Schett G, Mayr M, Willeit J, Kiechl S.

JAMA Cardiol. 2017 May 1;2(5):516-523. doi: 10.1001/jamacardio.2017.0064.

41.

Psychological distress, self-efficacy and glycemic control in type 2 diabetes.

Indelicato L, Dauriz M, Santi L, Bonora F, Negri C, Cacciatori V, Targher G, Trento M, Bonora E.

Nutr Metab Cardiovasc Dis. 2017 Apr;27(4):300-306. doi: 10.1016/j.numecd.2017.01.006. Epub 2017 Jan 31.

PMID:
28274728
42.

Association between subclinical left ventricular systolic dysfunction and glycemic control in asymptomatic type 2 diabetic patients with preserved left ventricular function.

Zoppini G, Bergamini C, Bonapace S, Rossi A, Trombetta M, Mantovani A, Toffalini A, Lanzoni L, Bertolini L, Zenari L, Bonora E, Targher G.

J Diabetes Complications. 2017 Jun;31(6):1035-1040. doi: 10.1016/j.jdiacomp.2017.01.021. Epub 2017 Feb 13.

PMID:
28258906
43.

Nonalcoholic fatty liver disease is associated with an increased prevalence of distal symmetric polyneuropathy in adult patients with type 1 diabetes.

Mantovani A, Rigolon R, Mingolla L, Pichiri I, Cavalieri V, Salvotelli L, Stoico V, Zoppini G, Bonora E, Targher G.

J Diabetes Complications. 2017 Jun;31(6):1021-1026. doi: 10.1016/j.jdiacomp.2017.01.024. Epub 2017 Feb 12.

PMID:
28254449
44.

Influence of health locus of control and fear of hypoglycaemia on glycaemic control and treatment satisfaction in people with Type 1 diabetes on insulin pump therapy.

Indelicato L, Mariano V, Galasso S, Boscari F, Cipponeri E, Negri C, Frigo A, Avogaro A, Bonora E, Trombetta M, Bruttomesso D.

Diabet Med. 2017 May;34(5):691-697. doi: 10.1111/dme.13321. Epub 2017 Feb 20.

PMID:
28145047
45.

Dietary intake and major food sources of polyphenols in people with type 2 diabetes: The TOSCA.IT Study.

Vitale M, Masulli M, Rivellese AA, Bonora E, Cappellini F, Nicolucci A, Squatrito S, Antenucci D, Barrea A, Bianchi C, Bianchini F, Fontana L, Fornengo P, Giorgino F, Gnasso A, Mannucci E, Mazzotti A, Nappo R, Palena AP, Pata P, Perriello G, Potenziani S, Radin R, Ricci L, Romeo F, Santini C, Scarponi M, Serra R, Timi A, Turco AA, Vedovato M, Zavaroni D, Grioni S, Riccardi G, Vaccaro O; TOSCA.IT Study Group.

Eur J Nutr. 2018 Mar;57(2):679-688. doi: 10.1007/s00394-016-1355-1. Epub 2016 Dec 21.

PMID:
28004268
46.

Circulating MicroRNA-122 Is Associated With the Risk of New-Onset Metabolic Syndrome and Type 2 Diabetes.

Willeit P, Skroblin P, Moschen AR, Yin X, Kaudewitz D, Zampetaki A, Barwari T, Whitehead M, Ramírez CM, Goedeke L, Rotllan N, Bonora E, Hughes AD, Santer P, Fernández-Hernando C, Tilg H, Willeit J, Kiechl S, Mayr M.

Diabetes. 2017 Feb;66(2):347-357. doi: 10.2337/db16-0731. Epub 2016 Nov 29.

47.

Polyphenol intake and cardiovascular risk factors in a population with type 2 diabetes: The TOSCA.IT study.

Vitale M, Vaccaro O, Masulli M, Bonora E, Del Prato S, Giorda CB, Nicolucci A, Squatrito S, Auciello S, Babini AC, Bani L, Buzzetti R, Cannarsa E, Cignarelli M, Cigolini M, Clemente G, Cocozza S, Corsi L, D'Angelo F, Dall'Aglio E, Di Cianni G, Fontana L, Gregori G, Grioni S, Giordano C, Iannarelli R, Iovine C, Lapolla A, Lauro D, Laviola L, Mazzucchelli C, Signorini S, Tonutti L, Trevisan R, Zamboni C, Riccardi G, Rivellese AA; TOSCA.IT Study Group.

Clin Nutr. 2017 Dec;36(6):1686-1692. doi: 10.1016/j.clnu.2016.11.002. Epub 2016 Nov 14.

PMID:
27890487
48.

Physical Activity Patterns in Normal-Weight and Overweight/Obese Pregnant Women.

Bacchi E, Bonin C, Zanolin ME, Zambotti F, Livornese D, Donà S, Tosi F, Baldisser G, Ihnatava T, Di Sarra D, Bonora E, Moghetti P.

PLoS One. 2016 Nov 9;11(11):e0166254. doi: 10.1371/journal.pone.0166254. eCollection 2016.

49.

A Novel Insulin/Glucose Model after a Mixed-Meal Test in Patients with Type 1 Diabetes on Insulin Pump Therapy.

Marchetti L, Reali F, Dauriz M, Brangani C, Boselli L, Ceradini G, Bonora E, Bonadonna RC, Priami C.

Sci Rep. 2016 Nov 8;6:36029. doi: 10.1038/srep36029.

50.

Incidence, prevalence, costs and quality of care of type 1 diabetes in Italy, age 0-29 years: The population-based CINECA-SID ARNO Observatory, 2002-2012.

Bruno G, Pagano E, Rossi E, Cataudella S, De Rosa M, Marchesini G, Miccoli R, Vaccaro O, Bonora E.

Nutr Metab Cardiovasc Dis. 2016 Dec;26(12):1104-1111. doi: 10.1016/j.numecd.2016.09.002. Epub 2016 Sep 20.

Supplemental Content

Loading ...
Support Center